U.S. markets closed
  • S&P Futures

    4,087.50
    +2.75 (+0.07%)
     
  • Dow Futures

    32,609.00
    +28.00 (+0.09%)
     
  • Nasdaq Futures

    12,569.00
    +8.75 (+0.07%)
     
  • Russell 2000 Futures

    1,838.70
    +1.50 (+0.08%)
     
  • Crude Oil

    114.16
    +1.76 (+1.57%)
     
  • Gold

    1,814.10
    -4.80 (-0.26%)
     
  • Silver

    21.68
    -0.07 (-0.32%)
     
  • EUR/USD

    1.0562
    +0.0007 (+0.06%)
     
  • 10-Yr Bond

    2.9680
    +0.0910 (+3.16%)
     
  • Vix

    26.10
    -1.37 (-4.99%)
     
  • GBP/USD

    1.2493
    +0.0001 (+0.01%)
     
  • USD/JPY

    129.2860
    -0.0720 (-0.06%)
     
  • BTC-USD

    30,577.90
    +600.72 (+2.00%)
     
  • CMC Crypto 200

    688.56
    +445.88 (+183.73%)
     
  • FTSE 100

    7,518.35
    +53.55 (+0.72%)
     
  • Nikkei 225

    26,976.08
    +316.33 (+1.19%)
     

Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2022 Results: February 8, 2022

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

BOSTON, Jan. 5, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2022 financial results at 6:00 am EST on Tuesday, February 8, 2022. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on February 8, 2022.

The call can be accessed with the following information:

U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 1649685

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/m6/p/qyrbnnofhttps://edge.media-server.com/mmc/p/qdj4xoqw

A replay of the conference call and webcast will be available for one year beginning on February 8, 2022 at 11:00 a.m. EST using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact:

Media Contact:

Olga Guyette, Director-Investor Relations

Josh Gitelson, Director-Global Communications

(781) 356-9763

(781) 356-9776

olga.guyette@haemonetics.com

josh.gitelson@haemonetics.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2022-results-february-8-2022-301454100.html

SOURCE Haemonetics Corporation